| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 46,775 | 60,581 | 52,213 | | Cost of Revenue | 23,959 | 28,660 | 28,321 | | | Gross Profit | 22,816 | 31,921 | 23,892 | | | Operating Expenses | | Research Development | 4,371 | 3,551 | 4,401 | | Selling General and Administrative | 22,262 | 25,275 | 22,716 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,817) | 3,095 | (3,225) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (472) | (323) | 113 | | Earnings Before Interest And Taxes | (4,289) | 2,772 | (3,112) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (4,289) | 2,772 | (3,112) | | Income Tax Expense | 2,839 | 237 | 68 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,128) | 2,535 | (3,180) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,128) | 2,535 | (3,180) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,128) | $2,535 | ($3,180) |
|
1.48% Nasdaq 
Income Statement
